The higher frequency of CD36-positive cells at diagnosis was identified in cases that presented recurrence of the disease,26 as well as a higher risk of relapse for CD36+ patients, thereby presenting a shorter leukemia-free survival rate.30 The gene discussed is CD36; the disease is leukemia.